Supplemental material
Journal of Medical Economics
Volume 26, 2023 - Issue 1
Open access
1,722
Views
0
CrossRef citations to date
0
Altmetric
Oncology
Evaluation of health economic impact of initial diagnostic modality selection for colorectal cancer liver metastases in suspected patients in China, Japan and the USA
Michael Blankenburga Bayer AG, Berlin, GermanyCorrespondence[email protected]
View further author information
, View further author information
Mostafa Elhamamya Bayer AG, Berlin, GermanyView further author information
, Diana Zhangb Bayer Healthcare Co. Ltd, Guangzhou, ChinaView further author information
, Naoto Fujikawac Bayer Yakuhin Co. Ltd, Osaka, JapanView further author information
, Alice Corbind Wickenstones Ltd, Carlow, Irelandhttps://orcid.org/0000-0002-4282-170XView further author information
, Guanyi Jind Wickenstones Ltd, Carlow, IrelandView further author information
, James Harrisd Wickenstones Ltd, Carlow, IrelandView further author information
& Gesine Knoblocha Bayer AG, Berlin, GermanyView further author information
show all
Pages 219-232
|
Received 04 Nov 2022, Accepted 24 Jan 2023, Published online: 10 Feb 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.